Mydriatic Regimens for Direct Ophthalmoscopy

First-Line Mydriatic Options

• The American Academy of Ophthalmology recommends a combination of tropicamide 0.5% and phenylephrine 2.5% as the most effective mydriatic regimen for direct ophthalmoscopy, providing adequate pupillary dilation with minimal side effects in approximately 90% of patients 1, 2
• Phenylephrine 2.5% can be used as an adjunct to tropicamide 0.5% when additional dilation is needed, particularly in patients with heavily pigmented irides 1

Patient-Specific Considerations

• For patients with heavily pigmented irides, the combination of tropicamide 0.5-1.0% and phenylephrine 2.5% is recommended for optimal dilation 1, 3
• For pediatric patients over 12 months, cyclopentolate 1% is often preferred as it provides both mydriasis and cycloplegia 1, 2
• For children under 6 months, a combination of cyclopentolate 0.2% and phenylephrine 1% is recommended 1, 3

Administration Technique

• Applying topical anesthetic prior to mydriatic drops can reduce stinging and improve drug penetration 3, 2
• Punctal occlusion during administration can reduce systemic absorption and associated side effects 3, 2

Precautions and Contraindications

• The American Academy of Ophthalmology recommends using mydriatics with caution in patients with narrow-angle glaucoma risk 2
• For patients with cardiovascular disease, tropicamide is preferred over phenylephrine due to fewer systemic cardiovascular effects 2
• Monitoring for potential side effects including hypersensitivity reactions, fever, dry mouth, tachycardia, nausea, vomiting, and behavioral changes is recommended 3

Alternative Approaches

• Atropine 1% may be used if maximum dilation is required, though it has a significantly longer duration of action (days rather than hours) 3, 2
• For patients who cannot tolerate phenylephrine, tropicamide 1% alone can provide adequate dilation for most ophthalmoscopy procedures 2